SNT 3.23% 3.0¢ syntara limited

Ann: Proposed issue of securities - SNT, page-9

  1. 125 Posts.
    lightbulb Created with Sketch. 5
    Have SNT continuous disclosure obligations been met ?
    Otherwise Syntara might have another problem with an aggrieved shareholder. This is the first time I have heard about issues with ARNA pharma.
    Extrodinary conincidence that a CR is ready to go when they announce contractual problems.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.